Expanded Access of MK-3475 in Metastatic Melanoma Patients with Limited to No Treatment Options
-
- STATUS
- Not Recruiting
Updated on 19 February 2024
Summary
The purpose of this study is to allow patients with limited or no other treatment options the opportunity to receive MK-3475.
Description
This protocol is a multi-site, worldwide treatment use protocol in patients with metastatic melanoma who have limited or no treatment options.
Details
| Condition | Melanoma |
|---|---|
| Age | 18years - 100years |
| Clinical Study Identifier | TX4135 |
| Last Modified on | 19 February 2024 |
How understandable was the trial content above?
Hard to understand
Easy to understand
Similar trials to consider
Loading...
Not finding what you're looking for?
Sign up as a volunteer to stay informed
Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.
Sign up as volunteerStudy Definition
WikipediaAdd a private note
- Select a piece of text.
- Add notes visible only to you.
- Send it to people through a passcode protected link.